通过专门的儿科喘中心,优化难以治疗和严重喘的儿童的护理:专家的实践经验和建议
M W Pijnenburg1, S Rubak2, H O Skjerven3,4
1Department of Paediatrics, Division of Respiratory Medicine and Allergology, Erasmus University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
BMC pediatrics
|March 28, 2024
概括
优化对患有严重喘的儿童的护理需要早期检测和专家转诊. 一个共识框架为管理严重儿科喘提供了实际指导,包括生物治疗和共享决策.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏学 过敏学
- 临床实践指南 临床实践指南
背景情况:
- 由于临床经验有限,儿童严重喘存在重大治疗挑战.
- 现有的指导方针往往有空白,需要实用建议来优化护理.
研究的目的:
- 开发一个基于共识的框架,以优化儿童严重喘的管理.
- 为临床医生提供关于早期检测,专家转诊和生物治疗选择的实际指导.
主要方法:
- 修改后的德尔菲共识方法,涉及16名欧洲儿科肺病学家和过敏学家.
- 纳入了利益相关者采访和对现有欧洲指南的分析.
主要成果:
- 优化护理的关键方面包括早期喘检测和转诊,儿科喘中心对生物疗法的专业管理以及共享决策.
- 定义了专家团队的原则,必要的测试和适当的家庭护理生物交付.
结论:
- 已经建立了一个优化重症儿科喘护理的实际框架.
- 鼓励实施这一共识建议,以提高患者的治疗成果,降低治疗负担.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
202
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
202
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291


